Very low rates of neutropenic complications and chemotherapy dose modifications in early breast cancer patients receiving adjuvant FEC-100 or TAC and an individualised G-CSF and anti-infective support: results of a retrospective chart review
2010 ◽
Vol 3
(3)
◽
pp. 123-128
2020 ◽
Vol 51
(3)
◽
pp. S3-S4
Keyword(s):
2021 ◽
Vol 19
(3.5)
◽
pp. EPR21-037
Keyword(s):
2020 ◽
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):